Rudolf Andrys Selected Research

BP-1-102

12/2021

Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudolf Andrys Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
1	Poisoning 09/2022
1	Neoplasms (Cancer) 12/2021
1	Epilepsy (Aura) 12/2020
1	Malaria 01/2020
1	Amyloid Plaque 01/2019
1	Organophosphate Poisoning 12/2018

Drug/Important Bio-Agent (IBA)

2	Monoamine Oxidase (MAO)IBA 01/2021 - 05/2020
2	Cholinesterases (Cholinesterase)IBA 01/2021 - 05/2020
2	AcetylcholinesteraseIBA 05/2020 - 01/2020
1	tabunIBA 09/2022
1	OximesIBA 09/2022
1	Cytotoxins (Cytolysins)IBA 12/2021
1	BP-1-102IBA 12/2021
1	Calcium Channels (Calcium Channel)IBA 01/2021
1	LigandsIBA 01/2021
1	Glycogen Synthase KinasesIBA 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2020
1	AntioxidantsIBA 12/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020
1	QuinolonesIBA 05/2020
1	InsecticidesIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Nerve AgentsIBA 12/2018
1	AntidotesIBA 12/2018
1	AcidsIBA 12/2018

Therapy/Procedure

2	Therapeutics 05/2020 - 01/2019